Welcome to our dedicated page for CTS SEC filings (Ticker: CTS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CTS Corporation (NYSE: CTS) SEC filings page aggregates the company’s regulatory disclosures, including the Form 8-K current reports cited in its public communications. These filings provide structured information on topics such as quarterly financial results, material definitive agreements, leadership changes, and board composition, giving investors a detailed view of how CTS reports key events and obligations.
CTS uses Form 8-K to furnish earnings press releases that summarize net sales, net earnings, margins, cash flow, and guidance ranges for annual sales and adjusted diluted earnings per share. These filings often include or reference investor presentations used in meetings with investors and analysts. The company also explains its use of non-GAAP financial measures alongside U.S. GAAP metrics and describes the categories of adjustments it applies, such as restructuring charges, environmental charges, acquisition-related adjustments, foreign exchange items, non-cash pension items, and certain discrete tax items.
Other CTS filings document material definitive agreements, such as the five-year unsecured revolving credit facility described in a Form 8-K. That filing outlines the size of the revolving credit facility, swing line and letter of credit sublimits, alternative currency sublimit, leverage and interest coverage covenants, and the replacement of a prior unsecured credit facility. Additional 8-K reports cover the appointment or resignation of senior officers, the election of new directors, committee assignments, and related compensation or indemnification arrangements.
On Stock Titan, CTS filings are updated as they become available from EDGAR, and AI-powered summaries can help explain the key points of lengthy documents. Investors can use this page to review CTS’s current reports on operations and financial condition, governance changes, and financing arrangements, as well as to understand how the company frames forward-looking statements and risk factors by referencing its Annual Report on Form 10-K and other filings.
CTS Corporation reports 2025 revenue of $541 million, up 5% from 2024, driven by strong growth in diversified end markets and disciplined execution under its Evolution 2030 strategy.
Medical sales reached $85 million (up 21%), industrial $140 million (up 12%), and aerospace and defense $83 million (up 20%). Transportation declined to $234 million, down 7% amid softer market conditions, but the company continued expanding powertrain-agnostic sensing and actuation offerings. CTS generated $102 million in operating cash flow and returned $62 million to shareholders via dividends and buybacks, supported by approximately $1 billion of booked business.
The 2026 Annual Meeting will be held on May 14, 2026, where shareholders will vote on electing eight directors, an advisory “Say-on-Pay” resolution for named executive officer compensation, and ratification of Grant Thornton LLP as independent auditor. Governance features include a largely independent, highly skilled board, majority voting for directors, robust committee structure, stock ownership guidelines, and a Code of Ethics.
CTS Corp: Amendment to Schedule 13G/A reporting Vanguard disaggregation and zero beneficial ownership. The filing states that The Vanguard Group completed an internal realignment and, in reliance on SEC Release No. 34-39538, certain subsidiaries will report beneficial ownership separately. The amendment reports 0 shares beneficially owned and 0% of the class.
The filing is signed by Ashley Grim as Head of Global Fund Administration on 03/26/2026 and reiterates that Vanguard and related managed accounts hold no single-third-party interest exceeding 5% of the class.
CTS Corp CFO Ashish Agrawal reported equity award activity involving common stock. He received a grant or award acquisition of 4,310 shares of common stock at a reference price of $52.94 per share, increasing his direct holdings to 111,054 shares immediately after that award.
The filing explains that these shares were earned from Performance Stock Units granted under the CTS Corporation 2018 Equity and Incentive Compensation Plan, based on certified performance for the 2023–2025 period. In a separate transaction on the same date, 2,024 shares were disposed of at $52.94 per share to satisfy tax withholding obligations upon vesting, leaving Agrawal with 109,030 directly owned shares.
CTS CORP President & CEO Kieran O'Sullivan reported equity compensation activity involving company common stock. On the certification of performance for a 2023-2025 period under the 2018 Equity and Incentive Compensation Plan, he acquired 16,873 shares as earned Performance Stock Units at a reference price of $52.94 per share. To cover tax withholding obligations tied to vesting of restricted shares, 7,526 shares were surrendered, also at $52.94 per share. After these grant and tax-withholding disposition entries, his directly held stake stands at 437,693 CTS shares.
CTS Corporation is an Indiana-based manufacturer of sensors, connectivity components and actuators serving transportation, industrial, medical, and aerospace and defense markets worldwide. It supplies primarily OEMs, tier-one suppliers and the U.S. government, with highly engineered, application-specific products.
In 2025, CTS’ net sales mix shifted toward diversification: transportation represented 43% of consolidated net sales, industrial 26%, medical 16%, and aerospace and defense 15%. Non‑U.S. operations generated 43.7% of net sales, reflecting substantial international exposure and manufacturing in China, Mexico, Europe and Asia.
The company remains customer‑concentrated: Toyota Motor Corporation accounted for 11.2% of 2025 net sales and Cummins 8.4%. At December 31, 2025, CTS employed 3,492 people, mainly in North America and Asia, and emphasized talent development, safety, diversity and an ethics-driven culture.
CTS highlights extensive risk factors, including reliance on a few large customers, cyclical end markets, supply chain constraints, inflation, geopolitical conflicts, environmental obligations, cybersecurity threats, technology change, climate-related regulation, indebtedness covenants and global compliance requirements. As of June 30, 2025, the aggregate market value of voting and non‑voting stock held by non‑affiliates was approximately $1.24 billion, with 28,695,710 shares outstanding on February 17, 2026.
O'SULLIVAN KIERAN M reported acquisition or exercise transactions in this Form 4 filing.
CTS Corp President & CEO Kieran M. O'Sullivan received a grant of 24,596 shares of common stock on February 12, 2026, at a price of $56.92 per share. This restricted stock award vests in equal installments over three years starting on the first anniversary of the grant date, contingent on continued service. Following this award, he beneficially owns 428,346 CTS shares directly.
Pacioni Mark R. reported acquisition or exercise transactions in this Form 4 filing.
CTS Corp’s Chief Legal and Administrative Officer, Mark R. Pacioni, received a restricted stock award of 3,693 shares of common stock on February 11, 2026, valued at $57.15 per share. The grant was made under the CTS Corporation 2018 Equity and Incentive Compensation Plan.
The restricted shares vest in equal installments over three years, beginning on the first anniversary of the grant date, and are subject to his continued service. Following this award, Pacioni beneficially owns 8,293 shares of CTS common stock, held directly.
CTS Corporation Senior Vice President Pratik Trivedi received an equity grant of 3,500 shares of common stock. The Form 4 reports this as an acquisition at a reference price of $57.15 per share, increasing his directly held stake to 11,438 shares.
The award is restricted stock granted under the CTS Corporation 2018 Equity and Incentive Compensation Plan. It vests in equal installments over three years, beginning on the first anniversary of the grant date, and is contingent on continued service with the company.
Agrawal Ashish reported acquisition or exercise transactions in this Form 4 filing.
CTS Corporation reported that its CFO, Ashish Agrawal, received a grant of common stock under the CTS Corporation 2018 Equity and Incentive Compensation Plan.
The award covers 6,002 shares of restricted stock at $57.15 per share. These shares vest in equal installments over three years, starting on the first anniversary of the grant date, as long as he continues in service. After this grant, Agrawal directly owns 106,744 shares of CTS common stock.
A shareholder of CTS has filed a notice of proposed sale under Rule 144 for 13,522 shares of common stock, with an aggregate market value of $764,155.26. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 02/12/2026.
The filing notes that these shares were acquired through multiple restricted stock vesting events under a registered plan in exchange for services rendered. The notice also includes a representation that the seller is not aware of any undisclosed material adverse information about CTS’s current or prospective operations.